Skip to Main Content

As Americans grapple with prescription drug costs, two new companies are being launched in hopes of transforming the opaque pharmaceutical supply chain that bedevils employers.

The Mark Cuban Cost Plus Drug Company and the Purchaser Business Group on Health, a coalition of 40 large private and public employers, are both creating pharmacy benefits managers. Known as PBMs, these controversial, behind-the-scenes entities play a crucial role in establishing prescription drug prices across the U.S.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

Create a display name to comment

This name will appear with your comment